Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.95 +0.01 (+1.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Return on Assets [ROA] (2011 - 2026)

Updated

Creative Medical Technology Holdings (CELZ) posted Return on Assets [ROA] of -76.35% for Q2 2026, down 1.73 percentage points from -74.62% a year earlier but up 4.50 percentage points from the prior quarter.

Analysis

Creative Medical Technology Holdings (CELZ) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Creative Medical Technology Holdings' Return on Assets [ROA] came in at -82.81%, down 19.61 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +5735.84 percentage points (FY2020 to FY2025).
  • In prior years, Creative Medical Technology Holdings' Return on Assets [ROA] was -63.20% in FY2024 (-27.84 pp), -35.36% in FY2023 (+31.26 pp), -66.62% in FY2022 (-387.19 pp) and 320.57% in FY2021 (+6139.23 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -803.93% in Q3 2021 to a high of 266.83% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -12.59 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2021, with a gain of 6622.87 percentage points; the weakest was Q4 2022, with a drop of 315.53 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -80.85% (Q1 2026), -87.76% (Q4 2025) and -92.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Creative Medical Technology Holdings 1.26 Mn 1.29 Mn - -76.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -76.35%
Mar 31, 2026 -80.85%
Dec 31, 2025 -87.76%
Sep 30, 2025 -92.01%
Jun 30, 2025 -74.62%
Mar 31, 2025 -81.11%
Dec 31, 2024 -81.04%
Sep 30, 2024 -71.49%
Jun 30, 2024 -65.10%
Mar 31, 2024 -51.89%
Dec 31, 2023 -45.52%
Sep 30, 2023 -73.75%
Jun 30, 2023 -63.71%
Mar 31, 2023 -58.35%
Dec 31, 2022 -48.71%
Sep 30, 2022 -34.00%
Jun 30, 2022 -52.25%
Mar 31, 2022 -93.12%
Dec 31, 2021 266.83%
Sep 30, 2021 -803.93%
API Access

Creative Medical Technology Holdings Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CELZ&period=max&api_key=YOUR_API_KEY